🔗 Share this article

A shadow market for unlicensed slimming medications is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which is still in research studies, is being promoted by social media influencers for its alleged fat-burning properties. Viewers are urged to message these profiles directly for supplier links, while also receiving promotional offers.

Active Commerce on Messaging Platforms

Additionally, a robust trade exists on Telegram, where communities with thousands of members share “before and after” images, administration instructions and claims of rapid UK delivery. Sellers promote the drug there before redirecting buyers to WhatsApp for transactions.

Understanding The Experimental Drug

Retatrutide is an investigational injection created by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Early trials suggest it could help patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being hailed digitally as the next Ozempic.

Medical Professionals Voice Worries

Nevertheless, doctors and pharmacists have cautions that the distribution of what remains an unapproved drug in the United Kingdom is worrisome and could lead to users administering substances of unknown origin.

Several professionals said the popularity for retatrutide could be linked to the increasing cost of licensed weight loss products such as Mounjaro.

Regulatory Status and Implementation

Selling the unapproved drug on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved medication that must not be promoted or supplied for personal consumption under the British medical regulations.

Some content creators try to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a restricted substance, but promotion and supply can still violate pharmaceutical, marketing, and consumer laws, potentially leading to fines, prosecution or imprisonment.

Service Reaction and Content Removal

Based on TikTok, the platform has taken down violative content and banned related keywords and search suggestions. The organization said it was committed to maintaining the service safe and investing in strengthening enforcement strategies.

Online Trading Operations

Research also discovered groups with up to 9,000 members marketing retatrutide using the platform's built-in search feature, which operates like a public directory. Typing “retatrutide” immediately displays channels with thousands of members, filled with photos of slimming results, positive reviews and detailed instructions for mixing or injecting at residence.

After minutes of entering one community, a vendor posted contact information, where most transactions take place. The vendor sent an guidebook and guaranteed delivery within two days. When questioned whether the product was genuine, one vendor said: “You can’t be sure.” Another shared a photo of a supposed laboratory certificate. Not one inquired about body mass, health issues or past usage.

Item Details and Pricing

Within these groups, messages show dark colored parcels with Royal Mail labels, claiming to contain new batches. One message stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors usually priced at 160 pounds for 20mg. When asked how much time a injector should be used, sellers give contradictory responses ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Measures

A spokesperson for the messaging service said it actively moderated dangerous content on its platform including content that promoted the “misuse of controlled medications”. The company noted that it eliminated “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are administering materials they cannot confirm. Although the research behind this drug is valid, these online products may not contain what they claim,” said a pharmacy expert, the director of pharmacy at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the surge in interest to recent price rises for authorized weight-loss medications such as Mounjaro. “With costs rising, patients are using social media. But fake treatments are highly dangerous. You can’t be certain what’s inside or whether the conditions they were produced in was sterile,” she said.

Her team has previously seen patients injured by personal administration from unverified suppliers. “We understand the frustration, but purchasing from messaging apps or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Producer Statement

A representative from the pharmaceutical company stated retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this point no one can market [it] for human use,” they said, adding that any product “falsely representing itself as a Lilly experimental product not yet approved … may subject patients to potentially significant health risks”.